Article Information
History
- August 1, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Haiyan Wu, MS1,
- Kwok Wong, PhD2,
- Shou-En Lu, PhD3,4,
- John Broggio, PhD2 and
- Lanjing Zhang, MD, FRCPath3,5,6,7,*
- 1Department of Clinical Epidemiology, Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK
- 2National Cancer Registration and Analysis Service, Public Health England, Birmingham B3 2PW, UK
- 3Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
- 4Department of Biostatistics, School of Public Health, Rutgers University, Piscataway, NJ
- 5Department of Pathology, Princeton Medical Center, Plainsboro, NJ
- 6Department of Biological Sciences, Rutgers University, Newark, NJ
- 7Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ
- ↵*Correspondence: Lanjing Zhang, MD, FRCPath, Department of Pathology, Princeton Medical Center, 1 Plainsboro Rd, Plainsboro, NJ 08536, USA. email: lanjing.zhang{at}rutgers.edu
Posted August 01, 2019.
Changing trends in proportional incidence and net survival of screened and nonscreened breast cancers among women in England
